Zhou Fang, Xu Hongmei
Department of Infectious and Digestive Diseases, Children's Hospital, Chongqing Medical University, Chongqing 400014, China.
Zhongguo Zhong Yao Za Zhi. 2010 Apr;35(7):908-11. doi: 10.4268/cjcmm20100724.
To investigate the effect and mechanism of emodin on acute intrahepatic cholestasis induced by alpha-naphthylisothiocyanate (ANIT) in rats.
Acute cholestatic model in rats was induced by ANIT. Normal control group, emodin group without ANIT treatment, model group and emodin group with ANIT treatment were set up. Liver function and pathological changes of hepatic tissue were examined. Real-time fluorescent quantitative RT-PCR was used to detect the mRNA levels of the hepatic transport protein genes mdr1a (multidrug resistance protein 1a), mdr1b (multidrug resistance protein 1b) mdr2 (multidrug resistance protein 2), The expression of P-gp were determined by Western blotting analysis.
Compared to the model group, Emodin treatment resulted in significant reductions in serum total bilirubin (TBiL), direct bilirubin (DBiL), alanine aminotransferase (ALT) and aspartate aminotransferase (AST), alkaline phosphatase (ALP), total bile acid (TBA) (P < 0.01 or P < 0.05). By examining the liver pathology, it was found that hepatic cellular change and necrosis, inflammatory cell infiltration and bile duct proliferation were notably alleviated in emodin model with ANIT treatment. Analysis of gene expression in livers from emodin-treated cholestatic rats revealed that mdr1a, mdr1b and mdr2 could be up-regulated (P < 0.01 or P < 0.05), expression of P-gp was increased in accordance with its mRNA (P < 0.05).
Emodin has a protective effect on hepatocytes and a restoring activity on cholestatic hepatitis. Mechanism of its action may be related to induce expression of the bile-metabolism-related transporter P-gp in the liver to prevent bile acids and other toxic compounds overaccumulation in hepatocytes and hepatic toxicity.
探讨大黄素对α-萘异硫氰酸酯(ANIT)诱导的大鼠急性肝内胆汁淤积的作用及机制。
采用ANIT诱导大鼠急性胆汁淤积模型。设立正常对照组、未用ANIT处理的大黄素组、模型组和用ANIT处理的大黄素组。检测肝功能及肝组织病理变化。采用实时荧光定量RT-PCR检测肝转运蛋白基因mdr1a(多药耐药蛋白1a)、mdr1b(多药耐药蛋白1b)、mdr2(多药耐药蛋白2)的mRNA水平,通过蛋白质免疫印迹分析测定P-糖蛋白的表达。
与模型组相比,大黄素治疗可使血清总胆红素(TBiL)、直接胆红素(DBiL)、丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)、碱性磷酸酶(ALP)、总胆汁酸(TBA)显著降低(P<0.01或P<0.05)。通过检查肝脏病理发现,用ANIT处理的大黄素模型中肝细胞变化和坏死、炎性细胞浸润及胆管增生明显减轻。对大黄素处理的胆汁淤积大鼠肝脏基因表达分析显示,mdr1a、mdr1b和mdr2可上调(P<0.01或P<0.05),P-糖蛋白的表达随其mRNA增加(P<0.05)。
大黄素对肝细胞有保护作用,对胆汁淤积性肝炎有恢复活性。其作用机制可能与诱导肝脏中胆汁代谢相关转运体P-糖蛋白的表达有关,以防止胆汁酸及其他有毒化合物在肝细胞中过度蓄积及肝毒性。